drugset / Trial / NCT02500667

A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

NCT02500667

NaSingle-groupOpen-labelBasic science

Summary

The present study is designed to assess the effects of Rifampin on the pharmacokinetics of N91115 in healthy subjects.

Timeline

Start
2015-06
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cavosonstat Small molecule 200 mg Oral
Subject Rifampin Small molecule 600 mg Oral

Indications

No indication recorded.